The Information Machine

Google DeepMind AI Co-Clinician Launch · history

Version 7

2026-05-02 13:18 UTC · 262 items

Narrative

The Google DeepMind AI co-clinician story has entered a fifth phase characterized by secondary documentation solidifying the competitive map, an emerging medical education research thread, and the first specific legal practice analysis of physician AI disclosure obligations. The core competitive structure established in the previous synthesis remains intact: OpenEvidence leads on scale and capital with a $12 billion valuation[1], $210 million in funding[2], 1 million physician-AI consultations in a single 24-hour period confirmed across multiple independent channels including PR Newswire[3] and Newswise[4], and the DeepConsult product[5]. A comparison article between OpenEvidence and Glass Health[6] introduces Glass Health as a named secondary competitor in the clinical consultation AI market — the first such comparison documented in this thread — expanding the competitive field beyond the previously mapped players (OpenEvidence, Abridge, Amazon, Microsoft, Epic). The MedGemma technical report has been updated to version 4 on arXiv[7], with continued secondary coverage from healthcare AI blogs[8][9] and the Google Research blog[10], suggesting the foundational model documentation is still evolving.

The most substantively new development in this cycle is the emergence of a medical student AI research literature directly relevant to the co-clinician's long-term workforce implications. Multiple peer-reviewed studies now document medical student AI attitudes and clinical skill acquisition: a JMIR article on AI utilization among medical students[11], a PMC systematic review on AI use impact on clinical skill acquisition and retention[12][13], a Springer article on medical student perceptions and attitudes[14], and a Nature study on attitudes of medical and life sciences students[15]. The central tension in this literature — whether AI tool adoption during training supports or impairs the development of independent clinical reasoning and examination skills — directly intersects with the co-clinician's weakest benchmark finding (underperformance on red flag identification and physical examination guidance[16]) and the r/medicalschool community engagement first documented in the previous synthesis[17]. If AI systems are associated with reduced clinical skill acquisition in trainees, the co-clinician's long-term deployment at medical school scale carries systemic risk that neither the Included Health randomized trial nor the OpenEvidence scale metrics are designed to capture.

The legal and governance discourse has gained new specificity. Medical Economics published an analysis specifically on AI malpractice law and physician disclosure obligations[18], adding a clinical practice legal voice beyond the academic frameworks previously documented (Stanford Law CodeX[19], Harvard Petrie-Flom Center[20]). The Medical Group Management Association (MGMA) published analysis on AI governance in medical group practices[21], introducing a practice management institutional voice focused on governance frameworks for the humans in the loop — a framing distinct from both the AMA's physician-leadership stance and the legal scholars' informed consent concerns. JAMA Network's continued engagement is documented through additional sources: a JAMA Network Open article on considerations in translating AI to improve care[22], a JAMA Facebook post calling for new research on AI in medicine[23], and a JAMA article on AI health and healthcare today and tomorrow[24], reinforcing JAMA's dual role as external validator and commercial partner in clinical AI deployment. The ARISE organization (Artificial Intelligence Research Initiative in Safety and Effectiveness) is confirmed as the institutional home of the Stanford-Harvard State of Clinical AI 2026 report[25], adding organizational specificity to a report that has generated multiple LinkedIn amplifications[26][27][28] and secondary coverage[29].

Additional amplification of the co-clinician announcement itself continues across trade media and social platforms: KuCoin covered the launch as a news flash[30], Distilinfo published a summary article[31], and LinkedIn user Daniel Rood amplified the initiative[32]. These items add volume rather than new analytical content, consistent with the 48-72 hour post-announcement amplification pattern. The AMA physician AI adoption story receives additional coverage from the ASCO Post[33] and a LinkedIn Pulse article[34], reinforcing the mainstream physician AI adoption backdrop but not adding new survey data beyond the 80%+ figure already established. The net effect of this synthesis cycle is consolidation: the competitive map, regulatory framework, and institutional discourse are all becoming better documented without fundamentally changing the story's structure or its central unresolved tensions.

Timeline

  • 2024-02: Hindustan Times reports Google DeepMind is working on an AI model to help diagnose patients, providing early public evidence the co-clinician initiative was in development at least two years before announcement. [165]
  • 2024-12-05: FDA finalizes recommendations simplifying the approval process for AI-enabled medical devices, providing a forming regulatory pathway for clinical AI systems in the US. [93]
  • 2025-04-11: Harvard Petrie-Flom Center publishes analysis arguing AI and big data are redefining informed consent rules in ways existing frameworks have not yet accommodated. [20]
  • 2026-01: ARISE (Artificial Intelligence Research Initiative in Safety and Effectiveness) publishes the Stanford-Harvard State of Clinical AI Report 2026, providing an institutional baseline assessment of the clinical AI boom and contextualizing the subsequent co-clinician launch as arriving at the documented peak of a multi-year growth curve. [76][25][26][29][77][27][28]
  • 2026-01-22: OpenEvidence doubles its valuation to $12 billion as physician adoption accelerates, establishing it as the highest-valued named competitor in the clinical consultation AI space. [1]
  • 2026-02-06: Epic releases native AI charting for integrated clinical documentation, entering the ambient documentation market as an EHR incumbent. [91]
  • 2026-02-20: Stanford Law School's CodeX publishes analysis arguing that existing healthcare AI disclosure frameworks — including the Mello framework — fail on their own terms when applied to AI in clinical care. [19]
  • 2026-02-27: AMA publishes National Advocacy Update and releases 2026 Physician Survey on Augmented Intelligence showing physician AI use doubled from 2023 to 2026; AMA position: physicians must lead AI tool development. [69][70][71][72][73]
  • 2026-03-10: OpenEvidence announces that AI collaborated with physicians in one million clinical consultations within 24 hours, confirmed via PR Newswire and Newswise press releases; Amazon launches its healthcare AI assistant on its website and app on the same date. [49][53][90][3][4]
  • 2026-04: OpenEvidence raises $210 million at a $3.5 billion valuation and launches DeepConsult, described as 'the first AI agent purpose-built for physicians,' with a dedicated user guide published on the OpenEvidence platform. [2][5][56]
  • 2026-04: Abridge partners with NEJM, JAMA, and UpToDate for AI clinical decision-making and evidence integration, expanding from AI scribe into evidence-backed clinical decision support embedded in the EHR workflow. [58][59][60][61][62][63][64][65][66][67]
  • 2026-04: MedGemma 1.5 technical report published on arXiv and updated to version 4, with detailed coverage on the Google Research blog documenting capabilities including 3D medical imaging interpretation and medical speech-to-text (MedASR). [45][166][167][168][169][46][170][171][172][7][10]
  • 2026-04-30: Google DeepMind publishes AI co-clinician blog post announcing a research initiative built on a 'triadic care' model, a dual-agent (Planner + Talker) architecture, and benchmark results from 98 primary care scenarios and 140-area consultation skill assessment. [16][43][48][173][30][31]
  • 2026-04-30: On the same day as the co-clinician announcement, Microsoft publishes a global healthcare AI transformation report and Amazon introduces the Amazon One Medical Health AI assistant, fragmenting healthcare AI news coverage across four simultaneous major announcements. [79][87][81]
  • 2026-04-30: DeepMind VP Research Pushmeet Kohli, health AI leader Alan Karthikesalingam, Google Research VP Avinatan Hassidim, and Google DeepMind researcher Joëlle Barral separately publish LinkedIn posts amplifying the initiative and confirming the Included Health partnership. [35][36][37][38][47]
  • 2026-04-30: Simultaneous social media amplification across X/Twitter, LinkedIn, and Reddit; Grok (xAI) publicly comments on demo; discussion spreads to r/whitecoatinvestor and r/OpenAI communities. [149][174][175][176][177][178][179][180][181][182][183][184][185][186][187][188][189][190][191][192][32]
  • 2026-04: Google announces strategic partnership with Included Health for a nationwide randomized study of AI in virtual care, confirmed by multiple sources including Joëlle Barral's LinkedIn post. [39][40][151][42][152][193][47]
  • 2026-05-01: Social media amplification continues globally; YouTube Shorts coverage begins; r/medicalschool Reddit discussion emerges as the first documented medical student engagement with the co-clinician; physician Derya Unutmaz MD amplifies Alan Karthikesalingam's deep-dive analysis on X. [127][128][129][130][48][140][131][132][133][134][17][135][173]
  • 2026-05: AMA publishes updated survey data showing more than 80% of physicians now use AI professionally, with ASCO Post and LinkedIn Pulse providing secondary coverage establishing mainstream physician AI adoption as the backdrop for the co-clinician's clinical trial phase. [74][33][34]
  • 2026-05: Medical Economics publishes analysis on AI malpractice law and physician disclosure obligations; MGMA publishes AI governance framework for medical group practices, adding practice management and legal practice voices to the governance discourse. [18][21]
  • 2026-08: (Upcoming) EU AI Act compliance deadline for medtech companies, including AI systems used as safety components in medical devices or direct patient-facing clinical roles — a binding regulatory forcing function for any clinical AI seeking EU market access. [112][114][116][117]

Perspectives

Google DeepMind / Google Research

Measured optimism with concrete deployment action: presents AI co-clinician as a research initiative with strong benchmark results, explicitly notes limitations, frames AI as operating under physician authority. The Included Health partnership, MedGemma 1.5 technical report (now at arXiv v4), and MedASR documentation signal active transition from research publication to structured clinical validation.

Evolution: reinforced: MedGemma arXiv technical report updated to version 4 suggests ongoing model development; secondary trade coverage of MedGemma continues across healthcare AI publications; no new primary DeepMind statements

[16][35][36][37][38][39][40][41][42][43][44][45][46][47][48][7][10]

OpenEvidence

Dominant scaled competitor: a $12B valuation, 1 million physician-AI consultations in a single 24-hour period confirmed via PR Newswire and Newswise press releases, $210M in funding, and the launch of DeepConsult — 'the first AI agent purpose-built for physicians' — with a published user guide. OpenEvidence is now documented as the primary comparison target in clinical AI platform comparisons, with Glass Health emerging as a secondary competitor in the same comparison space.

Evolution: reinforced: PR Newswire and Newswise coverage adds primary press release documentation to the 1M consultation milestone; DeepConsult user guide publication confirms the product is live and accessible; Glass Health comparison article introduces OpenEvidence as the market reference point against which other products are measured

[49][50][1][2][51][52][53][54][55][6][3][5][56][57][4]

Abridge

Systematically expanding from AI scribe to evidence-backed clinical decision support: NEJM, JAMA, and UpToDate integrations embed clinical evidence directly into the EHR workflow, competing for institutional medical content authority rather than consumer physician adoption.

Evolution: consistent: no new Abridge developments in current items; prior UpToDate partnership documentation holds

[58][59][60][61][62][63][64][65][66][67]

JAMA / medical journal establishment

Institutionally engaged with the evidentiary question and commercially embedded in clinical AI deployment: JAMA continues calling for new AI research, publishing considerations on translating AI to improve care, and maintaining its commercial partnership with Abridge — making journals simultaneous validators, critics, and commercial participants.

Evolution: deepened: JAMA Facebook post explicitly calling for new research on AI in medicine and JAMA Network Open translational article add active editorial engagement to the commercial partnership documentation; JAMA is now documented as both calling for evidence and commercially partnered with a deployment-stage product

[58][68][59][60][61][62][63][64][65][66][22][23][24]

American Medical Association (AMA)

Institutionally supportive of physician-led AI adoption: updated 2026 survey documents that more than 80% of physicians use AI professionally; AMA's explicit position is that physicians must lead in developing AI tools.

Evolution: reinforced: ASCO Post and LinkedIn Pulse secondary coverage of the AMA survey adds documentation breadth; AMA Ed Hub audio on AI and healthcare in 2026 adds a continuing medical education channel to the AMA's AI engagement

[69][70][71][72][73][74][75][33][34]

ARISE / Stanford-Harvard institutional research

The ARISE organization (Artificial Intelligence Research Initiative in Safety and Effectiveness) is confirmed as the institutional home of the State of Clinical AI 2026 report, lending it specific organizational credibility beyond the generic 'Stanford-Harvard' attribution used previously.

Evolution: clarified: ARISE's institutional identity as report publisher is now documented; LinkedIn amplifications from multiple healthcare AI professionals confirm the report's circulation in the clinical AI community

[76][26][25][29][77][27][28][78]

Medical Group Management Association (MGMA)

New governance voice: MGMA frames AI in medical group practices as a governance challenge requiring rules 'for the humans in the loop' — a practice management framing distinct from both the AMA's physician-leadership stance and legal scholars' informed consent focus.

Evolution: new voice: MGMA adds a medical practice administration perspective to the governance discourse, focused on institutional process rather than individual physician authority or patient rights

[21]

Legal practice community (Medical Economics)

Clinically focused legal analysis: Medical Economics frames the AI disclosure question through malpractice liability — whether physicians have an obligation to disclose when AI is used in care — adding a clinical practice risk management angle beyond the academic frameworks of Stanford Law and Harvard Petrie-Flom.

Evolution: new voice: Medical Economics adds a malpractice liability framing to the disclosure debate, shifting the question from 'what do existing frameworks require' (Stanford Law) to 'what are practicing physicians legally exposed to'

[18]

Microsoft

Competing in healthcare AI at global scale: published a healthcare AI transformation report on April 30, 2026 — the same day as DeepMind's co-clinician announcement — documenting AI progress for patients and medical professionals worldwide.

Evolution: consistent: no new Microsoft developments in current items

[79][80][81]

Amazon / Epic (incumbent tech and EHR competitors)

Amazon has formally introduced the Amazon One Medical Health AI assistant and scaled a health AI assistant to all US customers; Epic released native AI charting in February 2026 for integrated clinical documentation.

Evolution: consistent: no new Amazon or Epic developments in current items

[82][83][84][85][86][87][88][89][90][91]

FDA (US regulatory)

Moving toward streamlined AI medical device approval: December 2024 finalization of simplified approval recommendations signals a forming regulatory pathway for clinical AI. The FDA's SaMD and AI-enabled device frameworks remain the applicable regime but have not been applied to conversational diagnostic AI specifically.

Evolution: consistent: no new FDA developments in current items

[92][93][94][95][96][97]

EU regulatory and legal analysts

Compliance-focused with a concrete August 2026 deadline: EU AI Act Annex III high-risk classification applies to patient-facing clinical AI. A&O Shearman and EU AI Risk publish detailed compliance guidance for high-risk AI systems. At least one industry voice frames early EU compliance as a 'competitive edge' rather than a burden.

Evolution: reinforced: A&O Shearman and EU AI Risk compliance guides add authoritative legal firm and specialized resource documentation to the EU regulatory landscape; the compliance guidance infrastructure is now more fully documented

[98][99][100][101][102][103][104][105][106][107][108][109][110][111][112][113][114][115][116][117]

Legal and bioethics scholars (Stanford Law CodeX, Harvard Petrie-Flom Center)

Critically constructive: Stanford Law argues existing disclosure frameworks fail on their own terms; Harvard Petrie-Flom Center argues AI and big data are redefining informed consent rules in ways existing frameworks have not accommodated.

Evolution: consistent: no new legal/bioethics developments in current items

[118][119][120][121][122][19][20]

Medical student community and medical education research

A growing research literature on medical student AI use raises a structural concern: AI tool adoption during training may impair clinical skill acquisition and retention. Multiple 2026 studies examine medical student perceptions, attitudes, and the impact of AI on clinical reasoning development — directly relevant to the co-clinician's long-term deployment at the trainee level.

Evolution: significantly deepened: previously only the r/medicalschool Reddit discussion documented trainee engagement; now multiple peer-reviewed studies (JMIR, PMC, Springer, Nature) provide empirical grounding for the clinical skill acquisition concern, converting an anecdotal observation into a documented research tension

[17][11][123][14][12][15][13][124][125][126]

Physician community (individual practitioners, LinkedIn, X/Twitter)

Early-adopter enthusiasm backed by majority adoption data: physician Derya Unutmaz MD amplified Alan Karthikesalingam's analysis; LinkedIn Pulse coverage reinforces mainstream professional orientation.

Evolution: consistent: no new named physician voices; secondary coverage reinforces the 80%+ adoption baseline

[127][128][129][130][131][132][133][134][135][136][137][138][139][74][34]

Global multilingual social media amplifiers

Broadly enthusiastic; amplify headline benchmark numbers and the 'AI teammate not AI replacement' framing across multiple languages and platforms.

Evolution: consistent: amplification volume continues but no new multilingual or format developments in current items

[127][128][129][130][48][140][131][132][133]

AI medical scribe market (AWS HealthScribe, Nuance DAX, Freed, DeepCura, Clinically AI)

A mature, distinct market for documentation assistance AI operates in a separate category from diagnostic consultation AI, but Abridge's UpToDate partnership deepens its cross-over into evidence-backed decision support, blurring the category boundary.

Evolution: consistent: no new scribe market developments in current items

[141][142][143][144][145][146][147][148][66]

Tensions

  • Benchmark performance vs. real-world clinical safety: the AI co-clinician achieved strong scores in controlled simulations but underperformed physicians specifically in identifying red flags and guiding physical examinations — the safety-critical skills most consequential in actual clinical settings. [16][149][150]
  • Research trial vs. deployed scale: DeepMind's co-clinician is in the research-to-trial transition with the Included Health nationwide randomized study, while OpenEvidence has documented 1 million physician-AI clinical consultations in a single 24-hour period (confirmed via PR Newswire and Newswise) and reached a $12 billion valuation — creating a scale and capital gap that the randomized trial design cannot close in the near term. [16][151][42][152][49][1][2][53][47][3][4]
  • AI use and clinical skill development in trainees: a growing research literature on medical student AI use raises whether AI tool adoption during training impairs clinical skill acquisition and independent reasoning — directly relevant to the co-clinician's long-term deployment at the trainee level and intersecting with its weakest benchmark finding (red flag identification, physical examination guidance). [11][14][12][15][13][16][17]
  • US vs. EU regulatory gap with a concrete deadline: FDA is moving toward simplified AI medical device approval but has not applied its framework to conversational diagnostic AI; the EU AI Act's August 2026 compliance deadline for medtech companies creates a near-term forcing function Google has not publicly addressed, with A&O Shearman and EU AI Risk now publishing detailed high-risk compliance guidance. [153][154][155][156][157][112][114][93][94][95][96][115][116][117]
  • Patient transparency and consent — from academic frameworks to malpractice exposure: triadic care assumes patient awareness of AI involvement, but Stanford Law argues existing disclosure frameworks fail on their own terms, Harvard Petrie-Flom Center argues AI is redefining consent rules, and Medical Economics now frames the question as active malpractice liability for practicing physicians — converting an academic debate into a clinical risk management question. [158][159][160][118][119][120][121][122][19][105][20][18]
  • Competitive differentiation in a converging market: the clinical AI market is splitting between scribe/documentation tools and diagnostic/consultation AI, but Abridge's NEJM, JAMA, and UpToDate partnerships deepen its cross-over into consultation territory, OpenEvidence's DeepConsult directly mirrors DeepMind's physician-agent architecture at superior scale, and Glass Health now appears as a named additional competitor in the consultation AI comparison space — DeepMind has not articulated what architecturally or clinically distinguishes the co-clinician from any of these competitors. [82][83][84][85][86][161][141][142][144][145][147][148][49][58][2][66][6]
  • Physician leadership vs. industry-led AI deployment: the AMA's position that 'physicians must lead in developing AI tools' and MGMA's 'rules for the humans in the loop' governance framing both sit in tension with a model where major tech companies (Google, Amazon, Microsoft, Epic) design the architecture, benchmarks, and deployment partnerships — with 80%+ physician AI adoption now mainstream, the governance question is who controls the design. [69][70][73][16][41][74][79][81][21]
  • 'AI teammate' vs. 'AI doctor' branding: multiple social commentators analyze DeepMind's choice of 'co-clinician' over 'AI doctor' as a deliberate framing decision — raising the question of whether the naming obscures rather than resolves the autonomy questions at stake, particularly as OpenEvidence's DeepConsult operates at 1M-consultation scale without the same framing caution. [137][138][162][139][163][49][2]
  • 2026 as evidentiary inflection year: JAMA calls for new research on AI in medicine and has framed 2026 as potentially 'the year of real-world evidence,' but the Stanford HAI 2026 AI Index Report's medicine section and the ARISE clinical AI report document sector boom without resolving which evidentiary standard — scale or rigor — constitutes proof that AI improves patient outcomes. [49][58][68][42][76][47][25][164][78][23][24]
  • Same-day competitive narrative fragmentation: Microsoft's global healthcare AI report and Amazon's One Medical Health AI assistant launch both appeared on April 30, 2026 — the same day as DeepMind's co-clinician announcement — raising the question of whether DeepMind can establish distinctive narrative ownership in an environment where every major tech company is simultaneously announcing healthcare AI progress. [79][87][81][16][43]

Sources

  1. [1] OpenEvidence Doubles Valuation to $12bn as Physician Adoption Accelerates — reactive:deepmind-ai-co-clinician
  2. [2] OpenEvidence, the Fastest-Growing Application for Physicians in History, Announces $210 Million Round at $3.5 Billion Valuation: OpenEvidence also announces the wide release of OpenEvidence DeepConsult™—the first AI agent purpose-built for physicians | OpenEvidence — reactive:deepmind-ai-co-clinician
  3. [3] OpenEvidence Achieves Historic Milestone: 1 Million Clinical Consultations between Verified Doctors and an Artificial Intelligence System in a Single Day — reactive:deepmind-ai-co-clinician
  4. [4] OpenEvidence Achieves Historic Milestone: 1 Million Clinical ... — reactive:deepmind-ai-co-clinician
  5. [5] Deep Consult | User Guide | OpenEvidence — reactive:deepmind-ai-co-clinician
  6. [6] OpenEvidence vs Glass Health: 2026 Comparison for Physicians | Clinical AI Report — reactive:deepmind-ai-co-clinician
  7. [7] MedGemma Technical Report - arXiv — reactive:deepmind-ai-co-clinician
  8. [8] Google's MedGemma: Open AI Models Set to Revolutionize ... — reactive:deepmind-ai-co-clinician
  9. [9] MedGemma: A Deep Dive into Google's Open-Source AI for ... - Dr7.ai — reactive:deepmind-ai-co-clinician
  10. [10] MedGemma: Our most capable open models for health AI development — reactive:deepmind-ai-co-clinician
  11. [11] Utilization of AI Among Medical Students and Development of AI ... — reactive:deepmind-ai-co-clinician
  12. [12] AI Use for Medical Students: Impact on Clinical Skill Acquisition and ... — reactive:deepmind-ai-co-clinician
  13. [13] AI Use for Medical Students: Impact on Clinical Skill Acquisition and ... — reactive:deepmind-ai-co-clinician
  14. [14] Medical students perceptions and attitudes toward the use of ... — reactive:deepmind-ai-co-clinician
  15. [15] Attitudes of medical and life sciences university students ... - Nature — reactive:deepmind-ai-co-clinician
  16. [16] Enabling a new model for healthcare with AI co-clinician — DeepMind Blog (2026-04-30)
  17. [17] Google DeepMind AI co-clinician : r/medicalschool - Reddit — reactive:deepmind-ai-co-clinician
  18. [18] Inside AI malpractice law: Should physicians disclose when AI is used in care? | Medical Economics — reactive:deepmind-ai-co-clinician
  19. [19] Consent All the Way Down: What Healthcare AI Disclosure Inherits from Privacy Law - CodeX - Stanford Law School — reactive:deepmind-ai-co-clinician
  20. [20] Informed Consent, Redefined: How AI and Big Data Are Changing the Rules - Petrie-Flom Center — reactive:deepmind-ai-co-clinician
  21. [21] AI governance in medical group practices: Rules for the humans in the loop — reactive:deepmind-ai-co-clinician
  22. [22] Considerations in Translating AI to Improve Care - JAMA Network — reactive:deepmind-ai-co-clinician
  23. [23] JAMA — reactive:deepmind-ai-co-clinician
  24. [24] AI, Health, and Health Care Today and Tomorrow - JAMA Network — reactive:deepmind-ai-co-clinician
  25. [25] State of Clinical AI Report 2026 - ARISE — reactive:deepmind-ai-co-clinician
  26. [26] Stanford-Harvard Report on Clinical AI in 2026 | Moritz Hartmann posted on the topic | LinkedIn — reactive:deepmind-ai-co-clinician
  27. [27] Dr Lucinda Scharff's Post - State of Clinical AI Report 2026 - LinkedIn — reactive:deepmind-ai-co-clinician
  28. [28] Jonas Verbeke - State of Clinical AI Report 2026 - LinkedIn — reactive:deepmind-ai-co-clinician
  29. [29] Clinical AI Enters a New Phase, Stanford–Harvard Report Finds - BABL AI — reactive:deepmind-ai-co-clinician
  30. [30] Google DeepMind launches AI co-clinician research program with multimodal AI agent | KuCoin — reactive:deepmind-ai-co-clinician
  31. [31] Google DeepMind Launches AI Co-Clinician Initiative — reactive:deepmind-ai-co-clinician
  32. [32] AI co-clinician is Google DeepMind's new research initiative to help ... — reactive:deepmind-ai-co-clinician
  33. [33] AMA Survey Finds Rapid Growth in Physician AI Adoption - The ASCO Post — reactive:deepmind-ai-co-clinician
  34. [34] AI in medicine is moving fast—and physicians are already putting it ... — reactive:deepmind-ai-co-clinician
  35. [35] researching the path toward AI-augmented care | Pushmeet Kohli — reactive:deepmind-ai-co-clinician
  36. [36] Google DeepMind AI coscientist system validated by lab experiments | Alan Karthikesalingam MD PhD posted on the topic | LinkedIn — reactive:deepmind-ai-co-clinician
  37. [37] Google Research Collaborates with DeepMind on Multi-Agent ... — reactive:deepmind-ai-co-clinician
  38. [38] Dr. Vivek Natarajan, Research Scientist at Google DeepMind/Health ... — reactive:deepmind-ai-co-clinician
  39. [39] Today, Google is announcing a strategic partnership with Included Health to collaborate on a nationwide randomized study of AI in virtual care. AI systems capable of clinical reasoning and dialogue… | Mike Schäkermann | 19 comments — reactive:deepmind-ai-co-clinician
  40. [40] Google Partnership to Pilot New Offering in Outpatient Care Setting | TechTarget — reactive:deepmind-ai-co-clinician
  41. [41] Enabling physician-centered oversight for AMIE - Google Research — reactive:deepmind-ai-co-clinician
  42. [42] Collaborating on a nationwide randomized study of AI in real-world virtual care — reactive:deepmind-ai-co-clinician
  43. [43] AI co-clinician is our new research initiative to help explore how ... — reactive:deepmind-ai-co-clinician
  44. [44] Health AI — Google AI — reactive:deepmind-ai-co-clinician
  45. [45] MedGemma 1.5 Technical Report - arXiv — reactive:deepmind-ai-co-clinician
  46. [46] Next generation medical image interpretation with MedGemma 1.5 and medical speech to text with MedASR — reactive:deepmind-ai-co-clinician
  47. [47] In partnership with Included Health, we will be launching a first-of-its ... — reactive:deepmind-ai-co-clinician
  48. [48] Enabling a new model for healthcare with AI co-clinician — reactive:deepmind-ai-co-clinician (2026-05-01)
  49. [49] AI Collaborates with Physicians in 1M Clinical Consultations in 24 Hours | OpenEvidence posted on the topic | LinkedIn — reactive:deepmind-ai-co-clinician
  50. [50] AI Reshaping Clinical Decision-Making: OpenEvidence’s 2026 Strategic Outlook and Implications for the Greater Bay Area — reactive:deepmind-ai-co-clinician
  51. [51] The Clinical AI Landscape in 2026: ChatGPT, OpenEvidence, iatroX, Medwise, and What Comes Next | iatroX Clinical AI Insights — reactive:deepmind-ai-co-clinician
  52. [52] OpenEvidence Review — Clinical AI Report | Clinical AI Report — reactive:deepmind-ai-co-clinician
  53. [53] OpenEvidence Achieves Historic Milestone: 1 Million Clinical ... — reactive:deepmind-ai-co-clinician
  54. [54] OpenEvidence revenue, valuation & funding - Sacra — reactive:deepmind-ai-co-clinician
  55. [55] How OpenEvidence AI is transforming clinical decision-making — reactive:deepmind-ai-co-clinician
  56. [56] OpenEvidence — reactive:deepmind-ai-co-clinician
  57. [57] Daniel Nadler on OpenEvidence: Doctors' Favorite AI App — reactive:deepmind-ai-co-clinician
  58. [58] Abridge Partners with NEJM and JAMA for AI Clinical Decision-Making — reactive:deepmind-ai-co-clinician
  59. [59] Abridge Integrates Peer-Reviewed Evidence with NEJM & JAMA — reactive:deepmind-ai-co-clinician
  60. [60] Why Abridge is Embedding NEJM and JAMA Directly into the EHR — reactive:deepmind-ai-co-clinician
  61. [61] Abridge partners with medical journals to expand AI clinical decision support | Healthcare Dive — reactive:deepmind-ai-co-clinician
  62. [62] Abridge incorporates more clinical evidence into its decision support tools | Healthcare IT News — reactive:deepmind-ai-co-clinician
  63. [63] Partnership for clinical decision support moves AI to next level — reactive:deepmind-ai-co-clinician
  64. [64] Abridge to Bring NEJM & JAMA into Clinical Conversations — reactive:deepmind-ai-co-clinician
  65. [65] Abridge Partners with NEJM and JAMA to Integrate Peer-Reviewed ... — reactive:deepmind-ai-co-clinician
  66. [66] Abridge expands CDS with UpToDate, new content integrations — reactive:deepmind-ai-co-clinician
  67. [67] Abridge Clinical Decision Support | Evidence Shaped by Your Conversation — reactive:deepmind-ai-co-clinician
  68. [68] Will 2026 be the year of real-world evidence that #AI can actually ... — reactive:deepmind-ai-co-clinician
  69. [69] AMA: Physicians' use of AI doubled from 2023 to 2026 — reactive:deepmind-ai-co-clinician
  70. [70] [PDF] 2026 Physician Survey on Augmented Intelligence — reactive:deepmind-ai-co-clinician
  71. [71] Feb. 27, 2026: National Advocacy Update — reactive:deepmind-ai-co-clinician
  72. [72] Physician Survey on Augmented Intelligence | American Medical Association — reactive:deepmind-ai-co-clinician
  73. [73] AMA: Physicians must lead in developing AI tools to improve patient ... — reactive:deepmind-ai-co-clinician
  74. [74] More than 80% of physicians use AI professionally: AMA survey | American Medical Association — reactive:deepmind-ai-co-clinician
  75. [75] AI, Health Care, and What to Expect in 2026 - AMA Ed Hub — reactive:deepmind-ai-co-clinician
  76. [76] Clinical AI Has Boomed. A New Stanford-Harvard State of Clinical AI ... — reactive:deepmind-ai-co-clinician
  77. [77] [PDF] State of Clinical AI Report 2026 - Public Services Alliance — reactive:deepmind-ai-co-clinician
  78. [78] Medicine | The 2026 AI Index Report | Stanford HAI — reactive:deepmind-ai-co-clinician
  79. [79] Big Tech Enters Healthcare with Amazon Health, Microsoft Copilot ... — reactive:deepmind-ai-co-clinician
  80. [80] AI Solutions Optimized for Epic | Microsoft for Healthcare — reactive:deepmind-ai-co-clinician
  81. [81] AI Transformation Accelerates Progress in Healthcare Services for ... — reactive:deepmind-ai-co-clinician
  82. [82] Randomized Trial Protocol: Epic Generative AI Chart Summarization Tool to Reduce Ambulatory Provider Cognitive Task Load | medRxiv — reactive:deepmind-ai-co-clinician
  83. [83] Amazon's Healthcare AI vs. Everyone Else: Who Will Own the Doctor's Office in 2026? | AI Magicx Blog | AI Magicx — reactive:deepmind-ai-co-clinician
  84. [84] Epic AI Charting 2026: What Healthcare Providers Need to Know | SOAPNoteAI - SOAP Note Guides and Examples — reactive:deepmind-ai-co-clinician
  85. [85] Amazon makes a new bet on healthcare AI, rivaling Microsoft in the doctor's office – GeekWire — reactive:deepmind-ai-co-clinician
  86. [86] Amazon Scales Health AI Assistant to All US Customers — reactive:deepmind-ai-co-clinician
  87. [87] Today, we're excited to introduce the new Amazon One Medical ... — reactive:deepmind-ai-co-clinician
  88. [88] Epic's AI Scribe: Impact on Ambient Market and Predictions | Joshua Liu posted on the topic | LinkedIn — reactive:deepmind-ai-co-clinician
  89. [89] Amazon's move to get out ahead in health AI agent race — reactive:deepmind-ai-co-clinician
  90. [90] Amazon launches healthcare AI assistant on its website, app - Reuters — reactive:deepmind-ai-co-clinician
  91. [91] Epic Releases Native AI Charting for Integrated Clinical ... - HLTH — reactive:deepmind-ai-co-clinician
  92. [92] FDA Approval of Artificial Intelligence and Machine Learning ... - PMC — reactive:deepmind-ai-co-clinician
  93. [93] FDA finalizes recommendations simplifying approval process for medical devices that use AI | AHA News — reactive:deepmind-ai-co-clinician
  94. [94] Artificial Intelligence in Clinical Decision-Making: Regulatory Roadmap and Reimbursement Strategies | Akin Gump Strauss Hauer & Feld LLP - JDSupra — reactive:deepmind-ai-co-clinician
  95. [95] Artificial Intelligence in Software as a Medical Device - FDA — reactive:deepmind-ai-co-clinician
  96. [96] Artificial Intelligence-Enabled Medical Devices - FDA — reactive:deepmind-ai-co-clinician
  97. [97] Considerations for the Use of Artificial Intelligence - FDA — reactive:deepmind-ai-co-clinician
  98. [98] Journal of Medical Internet Research - AI Act Compliance Within the MyHealth@EU Framework: Tutorial — reactive:deepmind-ai-co-clinician
  99. [99] European Commission consultation shapes high-risk AI classification for life sciences in the EU | Osborne Clarke — reactive:deepmind-ai-co-clinician
  100. [100] Balancing Innovation and Control: The European Union AI Act ... — reactive:deepmind-ai-co-clinician
  101. [101] The EU AI Act & Pharma: Compliance Guide + Flowchart | IntuitionLabs — reactive:deepmind-ai-co-clinician
  102. [102] EU Commission Consultation on High-Risk AI Systems — reactive:deepmind-ai-co-clinician
  103. [103] AI in Clinical Trials & Compliance with the EU AI Act — reactive:deepmind-ai-co-clinician
  104. [104] Artificial Intelligence in healthcare — reactive:deepmind-ai-co-clinician
  105. [105] Article 6: Classification Rules for High-Risk AI Systems | EU Artificial Intelligence Act — reactive:deepmind-ai-co-clinician
  106. [106] Annex III: High-Risk AI Systems Referred to in Article 6(2) - EU AI Act — reactive:deepmind-ai-co-clinician
  107. [107] How the EU AI Act Affects Clinical Trials — reactive:deepmind-ai-co-clinician
  108. [108] EU AI Act Compliance: Annex III Extension Guide 2024 — reactive:deepmind-ai-co-clinician
  109. [109] EU AI Act for Medical Devices: SaMD Compliance ... - MDx CRO — reactive:deepmind-ai-co-clinician
  110. [110] High-Risk AI Systems Under the EU AI Act - DPO Consulting — reactive:deepmind-ai-co-clinician
  111. [111] High-Risk AI Systems: Strict Compliance Obligations You Need to ... — reactive:deepmind-ai-co-clinician
  112. [112] EU AI Act and Medical Devices: Compliance Guide 2026 — reactive:deepmind-ai-co-clinician
  113. [113] [PDF] Conformity Assessments under the EU AI Act: A step-by step guide — reactive:deepmind-ai-co-clinician
  114. [114] Implementation Timeline | EU Artificial Intelligence Act — reactive:deepmind-ai-co-clinician
  115. [115] The EU AI Act in Healthcare: From compliance to competitive edge — reactive:deepmind-ai-co-clinician
  116. [116] EU AI Act – What are the obligations for “high-risk AI systems”? — reactive:deepmind-ai-co-clinician
  117. [117] Complete Guide to EU AI Act High-Risk Classification | EU AI Act Resources | EU AI Risk — reactive:deepmind-ai-co-clinician
  118. [118] The Emerging Therapeutic Triad: How AI Complicates Informed ... — reactive:deepmind-ai-co-clinician
  119. [119] Artificial intelligence and the law of informed consent - Research Handbook on Health, AI and the Law - NCBI Bookshelf — reactive:deepmind-ai-co-clinician
  120. [120] The use of #AI tools in health care raises questions about patient ... — reactive:deepmind-ai-co-clinician
  121. [121] Patient Consent and The Right to Notice and Explanation of AI ... — reactive:deepmind-ai-co-clinician
  122. [122] Notification and Consent Preferences Based on U.S. National Survey — reactive:deepmind-ai-co-clinician
  123. [123] How Medical Teaching Will Look in 2026 with AI Driven Platforms — reactive:deepmind-ai-co-clinician
  124. [124] [PDF] Awareness and Attitude Toward Artificial Intelligence Among ... — reactive:deepmind-ai-co-clinician
  125. [125] Integrating artificial intelligence into medical education: a roadmap ... — reactive:deepmind-ai-co-clinician
  126. [126] Why AI in Medical Education Needs a 2026 Strategy — reactive:deepmind-ai-co-clinician
  127. [127] Google DeepMind Launches AI Co-Clinician - YouTube — reactive:deepmind-ai-co-clinician
  128. [128] Big week for AI: 🤖 — reactive:deepmind-ai-co-clinician (2026-05-02)
  129. [129] 🩺 Doctor + AI + Patient — reactive:deepmind-ai-co-clinician (2026-05-01)
  130. [130] Alan takes a deep dive into this remarkable new AI co-clinician from Google DeepMind. — reactive:deepmind-ai-co-clinician (2026-05-01)
  131. [131] Google DeepMind's AI co-clinician research is a reminder that the next healthcare AI wave may not replace doctors. It ma... — reactive:deepmind-ai-co-clinician (2026-05-01)
  132. [132] OpenAI introduces Advanced Account Security, DeepMind AI co-clinician | Next in AI | Astha La Vista #ai #artificialint... — reactive:deepmind-ai-co-clinician (2026-05-01)
  133. [133] AI News – May 1, 2026 — reactive:deepmind-ai-co-clinician (2026-05-01)
  134. [134] Google DeepMind's AI clinician aims to aid doctors | StartupHub.ai — reactive:deepmind-ai-co-clinician
  135. [135] AI co-clinician is our new research initiative to help explore how ... — reactive:deepmind-ai-co-clinician
  136. [136] AI co-clinician: enabling a new model for healthcare | Vishnu Ravi, MD — reactive:deepmind-ai-co-clinician
  137. [137] Google DeepMind isn’t building an AI doctor — it’s giving doctors an AI teammate. — reactive:deepmind-ai-co-clinician (2026-05-01)
  138. [138] Google DeepMind chamou de "co-clinician", não de "AI doctor" ou "diagnostic agent". — reactive:deepmind-ai-co-clinician (2026-05-01)
  139. [139] Google DeepMind's AI co-clinician runs live video with patients, guides physical exams in real time, and defers to physi... — reactive:deepmind-ai-co-clinician (2026-05-01)
  140. [140] الوضع صار اكثر جديه الان وممتع 😅 — reactive:deepmind-ai-co-clinician (2026-05-01)
  141. [141] Compare AWS HealthScribe vs. Clinically AI in 2026 — reactive:deepmind-ai-co-clinician
  142. [142] 2026 AI Medical Scribe Comparison: Top Tools for Clinicians | Twofold Health posted on the topic | LinkedIn — reactive:deepmind-ai-co-clinician
  143. [143] Healthcare AI Platforms: AWS vs Microsoft vs Google 2026 — reactive:deepmind-ai-co-clinician
  144. [144] Top AI Medical Scribe Companies in 2026 | Accuracy & Comparison — reactive:deepmind-ai-co-clinician
  145. [145] 15 Best AI Medical Scribes in 2026 (Ranked & Compared) - DeepCura — reactive:deepmind-ai-co-clinician
  146. [146] AWS HealthScribe vs. Clinically AI Comparison - SourceForge — reactive:deepmind-ai-co-clinician
  147. [147] 9 Best AI Scribes [2026] Comparisons, Benefits, Features, and More — reactive:deepmind-ai-co-clinician
  148. [148] 5 Best AI Medical Scribe Tools for 2026: In-Depth Comparison - Reddit — reactive:deepmind-ai-co-clinician
  149. [149] Google DeepMind’s real-time video AI doctor is here. — Rohan Paul Twitter (2026-04-30)
  150. [150] 🔴 DeepMind AI co-clinician: 98 blind-eval queries — doctors preferred it. 97/98 zero critical errors. — reactive:deepmind-ai-co-clinician (2026-05-01)
  151. [151] Google to evaluate conversational AI in virtual care — reactive:deepmind-ai-co-clinician
  152. [152] Google Research Partners with Included Health on Nationwide AI ... — reactive:deepmind-ai-co-clinician
  153. [153] Understanding FDA regulations for AI in SaMD | ICON plc — reactive:deepmind-ai-co-clinician
  154. [154] FDA Clearance & Clinical Adoption for AI Diagnostics | Bot Image — reactive:deepmind-ai-co-clinician
  155. [155] AI for Medical Device Regulation (FDA): Accelerating Approval Pathways - PPLE Labs — reactive:deepmind-ai-co-clinician
  156. [156] Demystifying Regulatory Hurdles: How to Navigate FDA Approval for ... — reactive:deepmind-ai-co-clinician
  157. [157] How to Get your AI models FDA approved: AI/ML Regulatory Landscape | Encord — reactive:deepmind-ai-co-clinician
  158. [158] 66% of US doctors now use AI in your care — often without saying ... — reactive:deepmind-ai-co-clinician
  159. [159] When AI is in the room: rethinking the medical conversation | InSight+ — reactive:deepmind-ai-co-clinician
  160. [160] AI is a 'third party' in the consultation room, say experts - BMJ Group — reactive:deepmind-ai-co-clinician
  161. [161] AI co-clinician from DeepMind will start a new product war provoking OpenEvidence, DoximityGPT, ChatGPT for Clinicians, ... — reactive:deepmind-ai-co-clinician (2026-05-01)
  162. [162] Google Deepmind just announced an AI that sits in the exam room with your doctor. — reactive:deepmind-ai-co-clinician (2026-05-01)
  163. [163] 醫院 AI 不再叫「工具」，改名「聯合醫師」。 — reactive:deepmind-ai-co-clinician (2026-05-01)
  164. [164] The 2026 AI Index Report | Stanford HAI — reactive:deepmind-ai-co-clinician
  165. [165] AI assistant for doctors? Google DeepMind working on AI model that ... — reactive:deepmind-ai-co-clinician
  166. [166] MedGemma 1.5 model card | Health AI Developer Foundations — reactive:deepmind-ai-co-clinician
  167. [167] MedGemma 1.5: Mastering 3D Medical Imaging and EHR Analysis — reactive:deepmind-ai-co-clinician
  168. [168] [2604.05081] MedGemma 1.5 Technical Report - arXiv — reactive:deepmind-ai-co-clinician
  169. [169] (PDF) MedGemma 1.5 Technical Report - ResearchGate — reactive:deepmind-ai-co-clinician
  170. [170] MedGemma 1.5: Run Medical AI on Your Own Servers - medgemma.pro — reactive:deepmind-ai-co-clinician
  171. [171] MedGemma 1.5 Extends Google's Open Model for Healthcare AI ... — reactive:deepmind-ai-co-clinician
  172. [172] MedGemma: Advanced AI Models for Medical Text and Image ... — reactive:deepmind-ai-co-clinician
  173. [173] Revolutionizing Healthcare: How Google DeepMind is Transforming ... — reactive:deepmind-ai-co-clinician
  174. [174] Google Deepmind launches AI Co-Clinician initiative - Reddit — reactive:deepmind-ai-co-clinician
  175. [175] Wow, this is so cool! Real-time AI doctor, via video, from Google ... — reactive:deepmind-ai-co-clinician
  176. [176] Google DeepMind deklassiert mit dem AI co-clinician GPT-5.4 im Medizin-Benchmark. Ein multimodales KI-Modell für Live-Te... — reactive:deepmind-ai-co-clinician (2026-04-30)
  177. [177] @AudioBooksRU @GoogleDeepMind @harvardmed @StanfordMed You're right—the demo shows the AI co-clinician directly intervie... — reactive:deepmind-ai-co-clinician (2026-04-30)
  178. [178] AI co-clinician: researching the path toward AI-augmented care — Google DeepMind https://t.co/6qXLmCd8Av — reactive:deepmind-ai-co-clinician (2026-04-30)
  179. [179] AI co-clinician: researching the path toward AI-augmented care - Google DeepMind https://t.co/JA2TobQ7jS — reactive:deepmind-ai-co-clinician (2026-04-30)
  180. [180] This AI co-clinician from Google DeepMind aced 97 out of 98 clinical tests — reactive:deepmind-ai-co-clinician (2026-04-30)
  181. [181] Google DeepMindが『AI co-clinician』を発表。マルチモーダルエージェントが医療現場をサポート。医療従事者とAIの協働で課題解決へ。ぼくも注視中。 by トウマ — reactive:deepmind-ai-co-clinician (2026-04-30)
  182. [182] Google DeepMind、医師を支援する AI co-clinician を発表🏥🤖 臨床エビデンス統合で 98 件中 97 件を正確に処理。テレメディシンでは一次医療医と同等のパフォーマンス。WHO が指摘する医療労働者 1000 ... — reactive:deepmind-ai-co-clinician (2026-04-30)
  183. [183] Excited to see DeepMind's AI co‑clinician initiative advancing multimodal support. To deliver value on healthcare teams... — reactive:deepmind-ai-co-clinician (2026-04-30)
  184. [184] NEWS: Google DeepMind announces AI co-clinician for healthcare. — reactive:deepmind-ai-co-clinician (2026-04-30)
  185. [185] Google Deepmind dropped ai co clinician research today — reactive:deepmind-ai-co-clinician (2026-04-30)
  186. [186] Google DeepMind unveils AI co-clinician. — reactive:deepmind-ai-co-clinician (2026-04-30)
  187. [187] NEWS: Google DeepMind launches an AI co-clinician research project to explore how multimodal agents can assist healthcar... — reactive:deepmind-ai-co-clinician (2026-04-30)
  188. [188] Google DeepMind just dropped an AI co-clinician 🤖 — reactive:deepmind-ai-co-clinician (2026-04-30)
  189. [189] Google DeepMind Just Solved a Major Problem with AI Doctors — reactive:deepmind-ai-co-clinician
  190. [190] 2026年4月30日、Google DeepMindが「AI co-clinician: researching the path toward AI-augmented care」を公開しました。臨床推論や診療判断を補助するAI共同臨床医... — reactive:deepmind-ai-co-clinician (2026-04-30)
  191. [191] BREAKING: google deepmind publishes research on an ai co-clinician model for healthcare. https://t.co/8uNF4AewKw — reactive:deepmind-ai-co-clinician (2026-04-30)
  192. [192] Google DeepMind's real-time video AI doctor is here. They just ... — reactive:deepmind-ai-co-clinician
  193. [193] Google Partners with Included Health on Nationwide AI in Virtual ... — reactive:deepmind-ai-co-clinician